Issam Makhoul is an Oncology physician affiliated with Central Arkansas Radiation Therapy Institute. OpenAlex indexes 162 publications with 2,110 citations (h-index 27); ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
8901 Carti Way
Little Rock, AR 722056523
Telephone
015-906-3000Provider last certified this registry record 9 Mar 2022.
Clinical trials
- The P10s-PADRE Basket Trial: Vaccination of Metastatic Cancer Patients
Sponsor: University of Arkansas
- Gut Microbiome & Gastrointestinal Toxicities as Determinants of Response to Neoadjuvant Chemo for Advanced Breast Cancer
Sponsor: University of Arkansas
- Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
Sponsor: University of Arkansas
Site investigatorPhase 2RecruitingNCT01530373
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20241 payment
- AstraZeneca Pharmaceuticals LPProgram year20241 payment
- CSL BehringProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
54.8%PD-1 inhibitor47.6%Pembrolizumab72%Nivolumab28%Part B, office-administered≥44 patientsMicrotubule Inhibitor5.9%Paclitaxel100%Part B, office-administered≥15 patients+ 10 more classes in this area
Blood & clotting
19.7%Iron, parenteral preparations12.4%Ferric derisomaltose100%Part B, office-administered≥68 patientsErythropoiesis-stimulating Agent7.3%Epoetin alfa100%Part B, office-administered≥42 patients+ 1 more class in this area
Metabolism & gastrointestinal
10.6%Substance P/Neurokinin-1 Receptor Antagonist6.7%Aprepitant100%Part B, office-administered≥17 patientsSerotonin-3 Receptor Antagonist3.8%Granisetron hydrochloride46%Palonosetron hcl26%Ondansetron hydrochloride25%Ondansetron Odt2%Ondansetron Hcl1%Part D + Part B<11 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2020–2021 per NIH RePORTER. The latest:
- Clinical Cytophone platform for detection of circulating melanoma cells.
Cytoastra, Llc
FY2021$96,800R41CA247027 - Clinical Cytophone platform for detection of circulating melanoma cells.
Cytoastra, Llc
FY2020$201,984R41CA247027
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”